MedTrace Logo

Comparison of Remifentanil-induced Postoperative Hyperalgesia Between Patients From Plain Area and Plateau Area

NCT05028049 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-08-31

No results posted yet for this study

Summary

Purpose:

1. To compare the incidence of postoperative hyperalgesia induced by remifentanil in patients undergoing gynecological laparoscopic surgery in plateau and plain areas
2. To compare the peri-operative analgesic requirements of patients in plain and plateau areas

Conditions

  • Pain, Postoperative
  • Anesthesia

Interventions

DRUG

Sufentanil injection

Sufentanil 0.3 μg/kg is intravenously administrated to maintain intraoperative analgesia

DRUG

Remifentanil Hydrochloride

Remifentanil 0.3ug/kg/min is intravenously administrated to maintain intraoperative analgesia

OTHER

plain areas

Patients should be long staying residents in plain areas (altitude level below 1,000 meters above sea level)

OTHER

plateau areas

Patients should be long staying residents in plateau areas (altitude level\>3000 meters above sea level)

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    lead OTHER

Principal Investigators

  • Guolin Wang, MD · Tianjin Medical University General Hospital

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2021-12-15
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05028049 on ClinicalTrials.gov